Awards & Other Accomplishments Archives | Be Korea-savvy

Archive by category Awards & Other Accomplishments

Bitdeer AI Named Top 100 Software Companies of 2024 by The Software Report

Bitdeer AI Named Top 100 Software Companies of 2024 by The Software Report

SINGAPORE, Nov. 21, 2024 (Korea Bizwire) – Bitdeer AI, part of Bitdeer Technologies Group (NASDAQ: BTDR), an emerging AI cloud service provider, is proud to announce its inclusion in the Top 100 Software Companies of 2024, ranked 8 in the Cloud Management by The Software Report. The Software Report’s Top 100 Software Companies award is [...]

Ardena’s New State-of-the-Art Nanomedicine Facility Secures Full GMP Approval for Manufacturing

Ardena’s New State-of-the-Art Nanomedicine Facility Secures Full GMP Approval for Manufacturing

OSS, The Netherlands, Nov. 19, 2024 (Korea Bizwire) – Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organisation (CDMO) with GMP facilities in Belgium, Spain, the Netherlands, and Sweden, announces the full Good Manufacturing Practice (GMP) approval of its expanded nanomedicine facility in Oss. Granted by the Dutch Healthcare Authority, the approval enables GMP manufacturing [...]

Junshi Biosciences Announces UK MHRA Approval for Marketing of Toripalimab

Junshi Biosciences Announces UK MHRA Approval for Marketing of Toripalimab

SHANGHAI, Nov. 16, 2024 (Korea Bizwire) – Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, and its wholly-owned subsidiary, TopAlliance Biosciences Inc. (TopAlliance Biosciences), announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved [...]

Sandoz receives European Commission approval for Afqlir® (aflibercept), further strengthening leading biosimilar portfolio

Sandoz receives European Commission approval for Afqlir® (aflibercept), further strengthening leading biosimilar portfolio

Afqlir® (aflibercept) approved to treat various retinal diseases, including neovascular age-related macular degeneration (nAMD) One of several biosimilar value drivers for Sandoz Sandoz remains committed to accelerating patient access by strengthening its biosimilar portfolio, reinforcing global and European leadership Basel, November 15, 2024 – Sandoz (SIX:SDZ/OTCQX:SDZNY), the global leader in generic and biosimilar medicines, today announced [...]

VistaJet Celebrates 20 Years of Excellence with Top Industry Recognition at AsBAA Icons of Aviation Awards for the Sixth Consecutive Time

VistaJet Celebrates 20 Years of Excellence with Top Industry Recognition at AsBAA Icons of Aviation Awards for the Sixth Consecutive Time

Hong Kong/Singapore, Nov. 14 (Korea Bizwire) – VistaJet, the world’s first and only global private aviation company, was honored with the title of Best AOC Charter Operator at the prestigious Asian Business Aviation Association (AsBAA) Icons of Aviation Awards. 2024 marks the sixth consecutive year* that VistaJet has been recognized for its industry-leading excellence, service, and [...]

Curium Announces ECLIPSE Trial Has Met Primary Endpoint, Demonstrating a Statistically Significant and Clinically Meaningful Benefit for Patients With PSMA-Positive Metastatic Castration Resistant Prostate Cancer

Curium Announces ECLIPSE Trial Has Met Primary Endpoint, Demonstrating a Statistically Significant and Clinically Meaningful Benefit for Patients With PSMA-Positive Metastatic Castration Resistant Prostate Cancer

ST. LOUIS, Nov. 13, 2024 (Korea Bizwire) – Curium, a world leader in nuclear medicine, announced today that its ECLIPSE trial met its primary endpoint. ECLIPSE is a pivotal Phase 3, multi-center, open-label, randomized clinical trial comparing the safety and efficacy of 177Lu-PSMA-I&T (INN: lutetium (177Lu) zadavotide guraxetan) versus hormone therapy in patients with metastatic castration-resistant [...]

Gala Games Takes Decentralization Further with GalaChain Integration on Bitrue

Gala Games Takes Decentralization Further with GalaChain Integration on Bitrue

SAN FRANCISCO, Nov. 13, 2024 (Korea Bizwire) – In a pivotal move for blockchain accessibility, Gala Games announces the integration of GalaChain with Bitrue, making it the first mainstream international exchange to support Gala’s proprietary layer-1 blockchain. Starting November 13, 2024, Bitrue users will be able to directly exchange GalaChain assets, eliminating the need to bridge to Ethereum [...]

The Sanborn Map Company, Inc. Receives Certification to ISO 9001:2015 Standard

The Sanborn Map Company, Inc. Receives Certification to ISO 9001:2015 Standard

COLORADO SPRINGS, Colo., Nov. 12, 2024 (Korea Bizwire) – Performance Review Institute (PRI) Registrar recognizes The Sanborn Map Company, Inc. for having met the stringent requirements of the 9001:2015 international standard, their ongoing commitment to satisfying stakeholders, and their dedication to continual improvement of their management system. The Sanborn Map Company, Inc. announces that it has [...]

Timor-Leste eliminates lymphatic filariasis as a public health problem

Timor-Leste eliminates lymphatic filariasis as a public health problem

DECATUR, Ga., Nov. 12, 2024 (Korea Bizwire) – The Mectizan Donation Program applauds Timor-Leste for eliminating lymphatic filariasis (LF) as a public health problem, a remarkable achievement that was recently validated by the World Health Organization (WHO). Timor-Leste is the fifth country in Southeast Asia to achieve this milestone and the first country in the region [...]

Clean Core Achieves Historic Burnup Milestone with its Thorium Fuel at US National Lab

Clean Core Achieves Historic Burnup Milestone with its Thorium Fuel at US National Lab

First-of-its-kind, thorium-based ANEEL™ fuel moves a step closer to commercialization CHICAGO, Nov. 12, 2024 (Korea Bizwire) – Clean Core Thorium Energy (Clean Core) announced that its patented ANEEL™ fuel (Advanced Nuclear Energy for Enriched Life) has reached a groundbreaking burnup milestone in the Advanced Test Reactor (ATR) at Idaho National Laboratory (INL). This achievement represents [...]